Heparin-induced thrombocytopenia: a review of concepts regarding a dangerous adverse drug reaction.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Revista da Associação Médica Brasileira

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ramb.2012.11.004PMID 23582558
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.

  2012cited by this paper
• Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• Assessment of the 4Ts Pretest Clinical Scoring System as a Predictor of Heparin‐Induced Thrombocytopenia

  2011cited by this paper
• Farmacovigilância da heparina no Brasil

  2011cited by this paper
• Accuracy of a prediction model for heparin-induced thrombocytopenia (HIT): an analysis based on individual patient data.

  2011cited by this paper
• Heparin pharmacovigilance in Brazil.

  2011cited by this paper
• Pharmacogenetics and rational drug use around the world.

  2011cited by this paper
• Heparin‐induced thrombocytopenia: Current status and diagnostic challenges

  2010cited by this paper
• Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia.

  2010cited by this paper
• The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia.

  2010cited by this paper
• Studies of the immune response in heparin-induced thrombocytopenia.

  2009cited by this paper
• Usefulness of pretest clinical score (4Ts) combined with immunoassay for the diagnosis of heparin-induced thrombocytopenia

  2008cited by this paper
• Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia.

  2008cited by this paper
• Goodman and Gilman's Manual of Pharmacology and Therapeutics

  2007cited by this paper
• Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options

  2006cited by this paper
• The management of heparin‐induced thrombocytopenia

  2006cited by this paper
• Australian Twin Registry: A Nationally Funded Resource for Medical and Scientific Research, Incorporating match and WATCH

  2006cited by this paper
• Delayed-onset heparin-induced thrombocytopenia.

  2005cited by this paper
• The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study.

  2005cited by this paper
• Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis

  2005cited by this paper
• Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis.

  2005cited by this paper
• Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients.

  2004cited by this paper
• An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.

  2003cited by this paper
• Laboratory Diagnosis of Heparin-Induced Thrombocytopenia and Monitoring of Alternative Anticoagulants

  2003cited by this paper
• Delayed-Onset Heparin-Induced Thrombocytopenia

  2003cited by this paper
• The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study.

  2003cited by this paper
• Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia.

  2003cited by this paper
• Heparin‐induced thrombocytopenia: pathogenesis and management

  2003cited by this paper
• Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.

  2002cited by this paper
• Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis

  2001cited by this paper
• Mechanisms of Venous and Arterial Thrombosis in Heparin-Induced Thrombocytopenia

  2000cited by this paper
• Impact of the patient population on the risk for heparin-induced thrombocytopenia.

  2000cited by this paper
• Fundamental Concepts in the Pathobiology of Heparin-Induced Thrombocytopenia

  2000cited by this paper
• Heparin-induced thrombocytopenia.

  1998cited by this paper
• Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism.

  1998cited by this paper
• Farmacovigilância: elementos para a discussão e perspectivas

  1998cited by this paper
• Pathogenicity of IgA and/or IgM antibodies to heparin–PF4 complexes in patients with heparin‐induced thrombocytopenia

  1996cited by this paper
• Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs

  1996cited by this paper
• Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

  1995cited by this paper
• Heparin-induced thrombocytopenia.

  1995cited by this paper
• Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.

  1994cited by this paper
• Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia.

  1994cited by this paper
• The Clinical Usefulness of the Platelet Aggregation Test for the Diagnosis of Heparin-Induced Thrombocytopenia

  1993cited by this paper
• Platelet Factor 4 Complexed to Heparin Is the Target for Antibodies Generated in Heparin-Induced Thrombocytopenia

  1992cited by this paper
• Effect of heparin on the in vivo release and clearance of human platelet factor 4.

  1983cited by this paper

• Heparin-Induced Hemorrhagic Bullous Dermatosis: A Rare Complication of Unfractionated Heparin

  2024cites this paper
• A comparison of heparinised and non-heparinised normal saline solutions for maintaining the patency of arterial pressure measurement cannulae after heart surgery

  2019cites this paper
• Sulfonated nanocellulose beads as potential immunosorbents

  2018cites this paper
• Oxidized Cladophora nanocellulose derivatives : Functionalization towards biocompatible materials

  2018cites this paper
• Role of Heparin in Arterial Line Flushing Solution on Platelet Count and Indwelling Arterial Catheter Patency after Cardiac Valvular Surgery

  2018cites this paper
• DIFFERENTIAL DIAGNOSIS OF NON-TRAUMATIC BRAIN HEMORRHAGE WITH ETIOPATHOGENETIS ASSOSIATION

  2018cites this paper
• Blood Compatibility of Sulfonated Cladophora Nanocellulose Beads

  2018cites this paper
• Risk Factors and Prophylaxis of Deep Vein Thrombosis and Pulmonary Embolism

  2017cites this paper
• Pentasaccharides for the treatment of deep vein thrombosis.

  2017cites this paper
• Identification of potential targets for an anticoagulant pectin.

  2017cites this paper
• Hemostasis and Anticoagulation Therapy

  2017cites this paper
• Trombocitopenia induzida por heparina em paciente com oclusão arterial aguda

  2016cites this paper
• Heparinized and Saline Solutions in the Maintenance of Arterial and Central Venous Catheters After Cardiac Surgery

  2015cites this paper
• Heparin for clearance of peripherally inserted central venous catheter in newborns: an in vitro study

  2015cites this paper
• Original ArticleHeparin for clearance of peripherally inserted central venous catheter in newborns: an in vitro studyHeparina para desobstrução de cateter venoso central de inserção periférica no recém-nascido: estudo in vitro

  2015cites this paper
• Heparina para desobstrução de cateter venoso central de inserção periférica no recém‐nascido: estudo in vitro

  2015cites this paper
• Effects of enoxaparin and unfractionated heparin in prophylactic and therapeutic doses on the fertility of female Wistar rats.

  2014cites this paper
• First Study of Intra-Arterial Delivery of Myogenic Mononuclear Cells to Skeletal Muscles in Primates

  2014cites this paper
• Fellow Master degree, Postgraduate Program in Health and Development of Midwestern Region, FAMED/UFMS, Campo Grande-MS, Brazil. Technical procedures, acquisition and interpretation of data, statistical analysis, manuscript writing, critical revision.

  2014cites this paper
• Thrombose und Schwangerschaft

  2014cites this paper
• Aptamer-functionalized Hydrogels for the Programmable Release of Growth Factors

  2014cites this paper
• Mesure de la génération de thrombine et son application pour la surveillance pharmacothérapeutique de l'héparine de faible poids moléculaire chez le chien

  2014cites this paper
• Diagnostik und Therapie venöser Thromboembolien in der Schwangerschaft und Postpartalperiode Diagnosis and treatment of venous thromboembolism during pregnancy and puerperium

  2013cites this paper
• Less Travelled Roads in Clinical Immunology and Allergy: Drug Reactions and the Environmental Influence

  2013cites this paper